Smartphone Twelve-Lead ECG Utility In ST-Elevation Myocardial Infarction II

Launched by ALIVECOR · Feb 20, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a new device created by AliveCor that helps doctors diagnose serious heart conditions, specifically types of heart attacks known as STEMI and NSTEMI. The device, called the AC 12-lead ECG System, works with smartphones to record heart activity in a way that is similar to standard ECG machines found in hospitals. The goal is to see if this new device can accurately diagnose heart issues just as well as the traditional ECGs.

To participate in this trial, individuals must be at least 18 years old and experiencing chest pain when they arrive at the Emergency Department. Participants will be asked to sign a consent form to ensure they understand the study. Throughout the trial, they will undergo tests using the new device to help researchers determine how well it works in diagnosing heart problems. This research is important because it could lead to quicker and more accessible heart evaluations, especially in emergency situations.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Male or female \> 18 years of age.
• • Ability to understand and sign a written informed consent form, which must be obtained prior to initiation of any study procedures.
• • Symptoms of chest pain upon presentation at the Emergency Department of the participating institution.
• Exclusion Criteria:
• • Inability or refusal of the patient and/or the patient's legally acceptable representative to provide written informed consent for any reason.
• • Other conditions that in the opinion of the Lead Investigator may increase risk to the subject and/or compromise the quality of the clinical trial.